Global Adalimumab Biosimilar Market Research Report 2021
Global Adalimumab Biosimilar Market Research Report 2021
The Adalimumab Biosimilar Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Adalimumab Biosimilar Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Adalimumab Biosimilar Market Overview:
Global Adalimumab Biosimilar Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Adalimumab Biosimilar involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Adalimumab Biosimilar Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Adalimumab Biosimilar market in 2020.
Global Adalimumab Biosimilar Market Segmentation
By Type, Adalimumab Biosimilar market has been segmented into:
Tablet
Oral Solution
By Application, Adalimumab Biosimilar market has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Adalimumab Biosimilar market are:
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
1. Market Overview of Adalimumab Biosimilar
1.1 Adalimumab Biosimilar Market Overview
1.1.1 Adalimumab Biosimilar Product Scope
1.1.2 Market Status and Outlook
1.2 Adalimumab Biosimilar Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Adalimumab Biosimilar Historic Market Size by Regions (2015-2020)
1.4 Adalimumab Biosimilar Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Adalimumab Biosimilar Sales Market by Type (2015-2026)
2.1 Global Adalimumab Biosimilar Historic Market Size by Type (2015-2020)
2.2 Global Adalimumab Biosimilar Forecasted Market Size by Type (2021-2026)
2.3 Tablet
2.4 Oral Solution
3. Covid-19 Impact Adalimumab Biosimilar Sales Market by Application (2015-2026)
3.1 Global Adalimumab Biosimilar Historic Market Size by Application (2015-2020)
3.2 Global Adalimumab Biosimilar Forecasted Market Size by Application (2021-2026)
3.3 Hospital Pharmacy
3.4 Retail Pharmacy
3.5 Online Pharmacy
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Adalimumab Biosimilar Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Adalimumab Biosimilar Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Adalimumab Biosimilar Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Adalimumab Biosimilar Business
5.1 AET BioTech
5.1.1 AET BioTech Company Profile
5.1.2 AET BioTech Adalimumab Biosimilar Product Specification
5.1.3 AET BioTech Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Amgen
5.2.1 Amgen Company Profile
5.2.2 Amgen Adalimumab Biosimilar Product Specification
5.2.3 Amgen Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Company Profile
5.3.2 Boehringer Ingelheim Adalimumab Biosimilar Product Specification
5.3.3 Boehringer Ingelheim Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Coherus Biosciences
5.4.1 Coherus Biosciences Company Profile
5.4.2 Coherus Biosciences Adalimumab Biosimilar Product Specification
5.4.3 Coherus Biosciences Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Fujifilm Kyowa Kirin Biologics
5.5.1 Fujifilm Kyowa Kirin Biologics Company Profile
5.5.2 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Product Specification
5.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 LG Life Sciences/Mochida Pharmaceutical
5.6.1 LG Life Sciences/Mochida Pharmaceutical Company Profile
5.6.2 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Product Specification
5.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Momenta Pharmaceuticals
5.7.1 Momenta Pharmaceuticals Company Profile
5.7.2 Momenta Pharmaceuticals Adalimumab Biosimilar Product Specification
5.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Oncobiologics
5.8.1 Oncobiologics Company Profile
5.8.2 Oncobiologics Adalimumab Biosimilar Product Specification
5.8.3 Oncobiologics Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Pfizer
5.9.1 Pfizer Company Profile
5.9.2 Pfizer Adalimumab Biosimilar Product Specification
5.9.3 Pfizer Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Samsung Bioepsis
5.10.1 Samsung Bioepsis Company Profile
5.10.2 Samsung Bioepsis Adalimumab Biosimilar Product Specification
5.10.3 Samsung Bioepsis Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Sandoz
5.11.1 Sandoz Company Profile
5.11.2 Sandoz Adalimumab Biosimilar Product Specification
5.11.3 Sandoz Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Zydus Cadila
5.12.1 Zydus Cadila Company Profile
5.12.2 Zydus Cadila Adalimumab Biosimilar Product Specification
5.12.3 Zydus Cadila Adalimumab Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Adalimumab Biosimilar Market Size (2015-2026)
6.2 North America Adalimumab Biosimilar Key Players in North America (2015-2020)
6.3 North America Adalimumab Biosimilar Market Size by Type (2015-2020)
6.4 North America Adalimumab Biosimilar Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Adalimumab Biosimilar Market Size (2015-2026)
7.2 East Asia Adalimumab Biosimilar Key Players in North America (2015-2020)
7.3 East Asia Adalimumab Biosimilar Market Size by Type (2015-2020)
7.4 East Asia Adalimumab Biosimilar Market Size by Application (2015-2020)
8. Europe
8.1 Europe Adalimumab Biosimilar Market Size (2015-2026)
8.2 Europe Adalimumab Biosimilar Key Players in North America (2015-2020)
8.3 Europe Adalimumab Biosimilar Market Size by Type (2015-2020)
8.4 Europe Adalimumab Biosimilar Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Adalimumab Biosimilar Market Size (2015-2026)
9.2 South Asia Adalimumab Biosimilar Key Players in North America (2015-2020)
9.3 South Asia Adalimumab Biosimilar Market Size by Type (2015-2020)
9.4 South Asia Adalimumab Biosimilar Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Adalimumab Biosimilar Market Size (2015-2026)
10.2 Southeast Asia Adalimumab Biosimilar Key Players in North America (2015-2020)
10.3 Southeast Asia Adalimumab Biosimilar Market Size by Type (2015-2020)
10.4 Southeast Asia Adalimumab Biosimilar Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Adalimumab Biosimilar Market Size (2015-2026)
11.2 Middle East Adalimumab Biosimilar Key Players in North America (2015-2020)
11.3 Middle East Adalimumab Biosimilar Market Size by Type (2015-2020)
11.4 Middle East Adalimumab Biosimilar Market Size by Application (2015-2020)
12. Africa
12.1 Africa Adalimumab Biosimilar Market Size (2015-2026)
12.2 Africa Adalimumab Biosimilar Key Players in North America (2015-2020)
12.3 Africa Adalimumab Biosimilar Market Size by Type (2015-2020)
12.4 Africa Adalimumab Biosimilar Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Adalimumab Biosimilar Market Size (2015-2026)
13.2 Oceania Adalimumab Biosimilar Key Players in North America (2015-2020)
13.3 Oceania Adalimumab Biosimilar Market Size by Type (2015-2020)
13.4 Oceania Adalimumab Biosimilar Market Size by Application (2015-2020)
14. South America
14.1 South America Adalimumab Biosimilar Market Size (2015-2026)
14.2 South America Adalimumab Biosimilar Key Players in North America (2015-2020)
14.3 South America Adalimumab Biosimilar Market Size by Type (2015-2020)
14.4 South America Adalimumab Biosimilar Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Adalimumab Biosimilar Market Size (2015-2026)
15.2 Rest of the World Adalimumab Biosimilar Key Players in North America (2015-2020)
15.3 Rest of the World Adalimumab Biosimilar Market Size by Type (2015-2020)
15.4 Rest of the World Adalimumab Biosimilar Market Size by Application (2015-2020)
16 Adalimumab Biosimilar Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Adalimumab Biosimilar Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|